Clinical trial

A Study Of PF-06647263 In Patients With Advanced Solid Tumors

NCT02078752

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2014-04-09

PhasePHASE1

Study timeline

Study start (actual)2014-04-09Date precision: day

Registry last updated2019-04-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Neoplasmsunresolved

Triple-Negative Breast Cancerunresolved

Interventions

PF-06647263DRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

BostonMassachusetts, United States3 NashvilleTennessee, United States2 Salt Lake CityUtah, United States2 HoustonTexas, United States1 DetroitMichigan, United States1 Las VegasNevada, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02078752 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.